Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
DAXX
REST API REST API
Homo sapiens
DAXX is differentially expressed in 217 experiments: 98 organism parts: spleen, bone marrow, ... (96 more);, 139 disease states: normal, acute lymphoblastic leukemia, ... (137 more);, 65 cell types 216 cell lines 34 compound treatments and 71 other conditions.
Synonyms DAP6
Orthologs daxx (Danio rerio)   Daxx (Mus musculus)   DAXX (Bos taurus)   ENSCING00000005773 (Ciona intestinalis)   Daxx (Rattus norvegicus)   daxx (Xenopus laevis)   DAXX_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, receptor signaling protein activity, negative regulation of transcription, DNA-dependent, protein binding, apoptosis, regulation of transcription, DNA-dependent, cytoplasm, cell cortex, protein N-terminus binding, heterochromatin, transcription factor binding, induction of apoptosis, neuron projection, activation of JUN kinase activity, transcription coactivator activity, nucleus, chromosome, centromeric region, cytokinesis after mitosis, protein homodimerization activity, chromosome, nucleoplasm, regulation of protein ubiquitination, enzyme binding, nucleolus, heat shock protein binding, ubiquitin protein ligase binding, androgen receptor binding, androgen receptor signaling pathway, induction of apoptosis via death domain receptors, interspecies interaction between organisms, PML body, p53 binding, cell body
InterPro Term Daxx
UniProt Accession A2AB94, Q4VX54, Q9UER7, Q5STR5, Q59FG7, F5H082
Search EB-eye ENSG00000204209
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-GEOD-6573, E-MEXP-1251, ... (24 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-MTAB-62, ... (25 experiments)

Factor Value U/D Experiments
A549
1
2
E-GEOD-3202, E-GEOD-6013
HL-60
2
E-GEOD-96, E-GEOD-24147
MCF-7
1
2
E-GEOD-19639, E-GEOD-20081, E-GEOD-3529
MDA-MB-435
1
E-MTAB-62
SKNDZ
1
E-MTAB-37
NCIH441
1
E-MTAB-37
210 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-22373, E-GEOD-21668, E-GEOD-4219, E-GEOD-20677, ... (38 experiments)

Factor Value U/D Experiments
CD56+ NK cells
2
E-TABM-145, E-AFMX-5
not specified
2
E-GEOD-18811, E-GEOD-11755
CD8+ T cell
1
2
E-AFMX-5, E-TABM-145, E-GEOD-6740
mononuclear cell
1
E-GEOD-6053
hematopoietic progenitor cells
1
E-MEXP-70
ADC
1
E-GEOD-19188
59 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-MEXP-25, E-GEOD-2466, E-GEOD-16363, ... (36 experiments)

Factor Value U/D Experiments
extranodal NK/T-cell lymphoma
2
E-TABM-702, E-GEOD-19067
uterine fibroid
2
E-GEOD-7307, E-MTAB-62
acute lymphoblastic leukemia
2
E-MTAB-62, E-MTAB-37
colon carcinoma
2
E-MTAB-62, E-MTAB-37
glioblastoma
2
E-GEOD-4290, E-MTAB-37
lung adenocarcinoma
2
E-MTAB-62, E-MTAB-37
133 more value(s).


Compound treatment

studied in E-GEOD-15205, E-TABM-782, E-GEOD-3720, E-GEOD-5824, E-GEOD-5099, ... (22 experiments)

Factor Value U/D Experiments
none
3
5
E-GEOD-5824, E-GEOD-412, E-MEXP-1958, E-GEOD-2649, E-GEOD-995, ... (8 experiments)
phoshate buffered saline
1
E-GEOD-3720
Cxcl12
1
E-GEOD-7307
heregulin
1
E-GEOD-6462
5-aza-2'-deoxycytidine
2
1
E-MEXP-1269
vanadium pentoxide
1
E-GEOD-5339
28 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
DMSO
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

cd1a
studied in E-GEOD-22601

cd3
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-MTAB-37, E-GEOD-6710, E-MEXP-1251, E-GEOD-2191, E-GEOD-21589, ... (7 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-1614, E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, E-MTAB-62 ... (5 experiments)

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-TABM-147, E-GEOD-19665

Environmental stress
studied in E-GEOD-1518, E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7578, E-GEOD-20847, E-MTAB-108, E-GEOD-6431

Genotype
studied in E-TABM-763, E-MEXP-149, E-GEOD-17476, E-GEOD-21750, E-GEOD-22593, ... (8 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-6432, E-GEOD-5681, E-GEOD-7011, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-1926, E-MEXP-2069, E-GEOD-16363, ... (25 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-6802

Karyotype
studied in E-GEOD-7214

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-426, E-TABM-84

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Performer
studied in E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-22309, E-GEOD-21750

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19246

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-GEOD-12438, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, E-MEXP-2759 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-MEXP-70

Sex
studied in E-GEOD-7540, E-GEOD-7307

Stimulation
studied in E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Test result
studied in E-TABM-276

Tissue
studied in E-GEOD-30573

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-15799, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-89

Processing time: 0.508 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM